These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8254888

  • 21. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
    Abe T, Fukuoka T, Sato Y, Ito K, Sei M.
    Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
    [Abstract] [Full Text] [Related]

  • 22. [Clinical and pharmacokinetic evaluation of cefodizime in children].
    Hirabayashi Y, Higashino H, Kino M, Nobori U, Okazaki H, Kitamura N, Kobayashi Y.
    Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
    [Abstract] [Full Text] [Related]

  • 23. [Antibacterial activities of sisomicin against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y.
    Jpn J Antibiot; 1992 Aug; 45(8):990-1002. PubMed ID: 1433905
    [Abstract] [Full Text] [Related]

  • 24. [Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates].
    Kosakai N.
    Jpn J Antibiot; 1989 May; 42(5):1125-65. PubMed ID: 2664255
    [Abstract] [Full Text] [Related]

  • 25. [Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].
    Igari J.
    Jpn J Antibiot; 1990 Oct; 43(10):1723-82. PubMed ID: 2086814
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kondou T, Kobayashi K, Satou K, Matsumiya H, Saito A.
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [Abstract] [Full Text] [Related]

  • 31. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K, Terai T, Igari J, Inoue H, Nakadate T, Oguri T, Suwabe A, Obata R, Ikemoto H, Ohno I, Okada S, Hayashi K, Mori T, Nakano K, Arakawa M, Gejyo F, Igarashi K, Yokouchi H, Okada M, Ito A, Sumitomo M, Aoki N, Matsushima T, Niki Y, Kitamura N, Suga M, Suzuki Y, Karasawa Y, Tosaka M, Nakata K, Nakatani T, Kohno S, Tomono K, Miyazaki Y, Inagawa H, Hirakata Y, Aoki S, Matsuda J, Kudo K, Kobayashi N, Kinoshita T, Konosaki H, Nasu M, Nagai H, Kobayashi H, Kawai S, Takayasu S, Hiramatsu K, Nakano T.
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [Abstract] [Full Text] [Related]

  • 33. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution].
    Kosakai N, Kumamoto Y, Sakai S, Hirose T, Shigeta S, Shiraiwa Y, Miura Y, Ogata M, Tazaki H, Iri H.
    Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808
    [Abstract] [Full Text] [Related]

  • 36. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N.
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [Abstract] [Full Text] [Related]

  • 37. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. IV. Synergistic action with dibekacin].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1992 May; 45(5):478-88. PubMed ID: 1512933
    [Abstract] [Full Text] [Related]

  • 38. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Sensitivity of the recent bacterial isolates to cefotaxime and other cephem antibiotics].
    Fujita S, Yoshida T, Okado N, Matsubara F.
    Jpn J Antibiot; 1983 Oct; 36(10):2887-92. PubMed ID: 6325747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.